Option Care Health (NASDAQ:OPCH) Shares Gap Up – Here’s Why

Option Care Health, Inc. (NASDAQ:OPCH) shares gapped up before the market opened on Tuesday. The stock had previously closed at $23.37, but opened at $31.04. Option Care Health shares last traded at $31.0250, with a volume of 22,664,453 shares.

Option Care Health News Summary

Here are the key news stories impacting Option Care Health this week:

• Positive Sentiment: McKesson and CD&R agreed to acquire Option Care Health for $32.05 per share, implying an enterprise value of approximately $5.8 billion and a premium of about 37% to the prior closing price. The all-cash transaction provides a clear takeover valuation and is the primary reason for the stock’s move higher. CD&R and McKesson Corporation Sign Agreement to Acquire Option Care Health
• Positive Sentiment: Reports that acquisition discussions had reached an advanced stage, followed by the definitive agreement, triggered substantial investor interest and temporarily halted OPCH trading pending news. Option Care Health’s Shares Soar as Acquisition Talks Advance
• Neutral Sentiment: The deal remains subject to customary closing conditions and approvals. The stock’s trading level below the $32.05 offer price suggests investors may be accounting for transaction-completion risk.
• Neutral Sentiment: A Zacks article reviews whether OPCH is undervalued using value, growth, momentum and earnings-estimate trends, but the available report excerpt does not provide a definitive rating or new company-specific catalyst. Is Option Care Health Stock Undervalued Right Now?
• Negative Sentiment: Brodsky & Smith announced an investor investigation involving Option Care Health. The notice provides few details, but such investigations can introduce legal and reputational uncertainty around the transaction. Brodsky & Smith Shareholder Update

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on the stock. Wall Street Zen raised shares of Option Care Health from a “hold” rating to a “buy” rating in a report on Saturday, August 1st. Zacks Research upgraded shares of Option Care Health from a “strong sell” rating to a “hold” rating in a research report on Monday, July 6th. The Goldman Sachs Group initiated coverage on Option Care Health in a research note on Monday, June 8th. They set a “neutral” rating and a $22.00 target price for the company. Citigroup reaffirmed a “market outperform” rating on shares of Option Care Health in a report on Tuesday. Finally, Stephens reiterated an “equal weight” rating and issued a $24.00 price target (down from $30.00) on shares of Option Care Health in a research note on Friday, July 17th. Seven equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $29.92.

Option Care Health Price Performance

The stock has a market capitalization of $4.64 billion, a price-to-earnings ratio of 23.31, a P/E/G ratio of 1.30 and a beta of 0.58. The company has a fifty day simple moving average of $23.61 and a 200 day simple moving average of $23.54. The company has a debt-to-equity ratio of 0.91, a quick ratio of 0.98 and a current ratio of 1.47.

Option Care Health (NASDAQ:OPCH) last posted its quarterly earnings data on Wednesday, July 29th. The company reported $0.45 earnings per share for the quarter, topping the consensus estimate of $0.43 by $0.02. Option Care Health had a net margin of 3.68% and a return on equity of 18.74%. The company had revenue of $1.44 billion during the quarter, compared to analysts’ expectations of $1.42 billion. During the same period in the prior year, the company posted $0.41 earnings per share. Option Care Health’s revenue for the quarter was up 1.9% compared to the same quarter last year. Option Care Health has set its FY 2026 guidance at 1.850-1.920 EPS. Equities research analysts forecast that Option Care Health, Inc. will post 1.7 EPS for the current fiscal year.

Hedge Funds Weigh In On Option Care Health

Large investors have recently modified their holdings of the company. Arrowstreet Capital Limited Partnership lifted its stake in shares of Option Care Health by 6.2% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 4,248,425 shares of the company’s stock valued at $135,355,000 after buying an additional 247,118 shares in the last quarter. Dimensional Fund Advisors LP boosted its position in shares of Option Care Health by 0.9% during the first quarter. Dimensional Fund Advisors LP now owns 3,876,856 shares of the company’s stock valued at $104,368,000 after buying an additional 36,208 shares during the last quarter. Southpoint Capital Advisors LP grew its holdings in Option Care Health by 20.0% during the first quarter. Southpoint Capital Advisors LP now owns 3,600,000 shares of the company’s stock worth $96,912,000 after buying an additional 600,000 shares in the last quarter. Sumitomo Mitsui Trust Group Inc. purchased a new stake in Option Care Health in the 1st quarter valued at $70,287,000. Finally, Norges Bank purchased a new stake in Option Care Health in the 4th quarter valued at $61,787,000. 98.05% of the stock is currently owned by institutional investors.

Option Care Health Company Profile

Option Care Health, Inc (NASDAQ: OPCH) is a provider of home and alternate-site infusion services in the United States. The company works with patients, physicians, hospitals, health plans and pharmaceutical manufacturers to deliver and manage infusion therapy outside traditional hospital settings, including in patients’ homes, ambulatory infusion suites and other community-based locations.

Its services include the provision and administration of specialty medications and other infusion therapies for conditions such as infections, immune disorders, chronic diseases and nutritional deficiencies.